Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Japan's Takara Bio To Manufacture Mrna Vaccines On Contract - Nikkei

Nov 3 (Reuters) - Nikkei:
    * JAPAN'S TAKARA BIO TO MANUFACTURE MRNA VACCINES ON
CONTRACT -
NIKKEI
    * TAKARA BIO WILL REPURPOSE EQUIPMENT AT ITS MAINSTAY PLANT
IN
KUSATSU, A CITY IN SHIGA PREFECTURE, WITH PRODUCTION STARTING AS
SOON AS JANUARY - NIKKEI
    * TAKARA BIO PLANS TO HAVE ENOUGH CAPACITY TO MAKE THE
EQUIVALENT
OF 12 MILLION PFIZER VACCINE DOSES A YEAR - NIKKEI

Further company coverage:  4974.T 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Takara Bio

See all news